Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
8.30
+0.10 (1.22%)
At close: Aug 13, 2025, 4:00 PM
8.30
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:42 AM EDT
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $740.09 million as of August 14, 2025. Its market cap has increased by 460.97% in one year.
Market Cap
740.09M
Enterprise Value
565.23M
1-Year Change
460.97%
Ranking
Category
Stock Price
$8.30
Market Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has decreased from $1.07B to $740.09M, a decrease of -30.78%. That is a compound annual growth rate of -9.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 740.09M | 187.58% |
| Dec 31, 2024 | 257.35M | -74.11% |
| Dec 29, 2023 | 993.86M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |